PAR 6.98% 20.0¢ paradigm biopharmaceuticals limited..

Fast Track, page-3

  1. 1,191 Posts.
    lightbulb Created with Sketch. 122
    I brought in last week, the Capital Raising has provided an opportunity to buy at a significant discount to its recent trading pattern and hopefully unrealised potential.

    Would expect the CR churn to wash out over the next few months and then news flow to see the stock trade well above pre CR levels by years end.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.